Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.

You might also like
Harvard President Alan Garber Helps First-Years Move In
As a potential settlement with the Trump administration looms, Garber gets students settled.
Harvard’s New Online Orientation Emphasizes Intellectual Paths
A summer course for first-years focuses on academic success, diverse viewpoints.
The Pump Celebrates Its 85th Birthday
Giving Harvard traditions their due
Most popular
Explore More From Current Issue

Do Mitochondria Hold the Power to Heal?
From Alzheimer’s to cancer, this tiny organelle might expand treatment options.

Why Harvard Needs International Students
An ed school professor on why global challenges demand global experiences